Protection against chemotherapy-induced hair loss

10/11/13

Permalink 10:42:57 am, by mdst, 156 words, 1840 views   English (US)
Categories: Announcements [A]

Protection against chemotherapy-induced hair loss

Haslam IS, et al, Protection against chemotherapy-induced alopecia: targeting ATP-binding cassette transporters in the hair follicle? Trends Pharmacol Sci. 2013 Oct 4. pii: S0165-6147(13)00164-8.

Abstract

Currently, efficacious treatments for chemotherapy-induced alopecia (hair loss) are lacking, and incidences of permanent hair loss following high-dose chemotherapy are on the increase. In this article, we describe mechanisms by which the pharmacological defense status of the hair follicle might be enhanced, thereby reducing the accumulation of cytotoxic cancer drugs and preventing or reducing hair loss and damage. We believe this could be achieved via the selective increase in ATP-binding cassette (ABC) transporter expression within the hair follicle epithelium, following application of topical agonists for regulatory nuclear receptors. Clinical application would require the development of hair follicle-targeted formulations, potentially utilizing nanoparticle technology. This novel approach has the potential to yield entirely new therapeutic options for the treatment and management of chemotherapy-induced alopecia, providing significant psychological and physical benefit to cancer patients.

Pingbacks:

No Pingbacks for this post yet...

Hair Loss

Hair Loss and Hair loss treatment

Search

Linkblog

b2evolution

  • Cormorbid conditions in Alopecia Areata

    JAMA Dermatol. 2013 May 22:1-5. doi: 10.1001/jamadermatol.2013.3049. [Epub ahead of print]

    Autoimmune, Atopic, and Mental Health Comorbid Conditions Associated With Alopecia Areata in the United States.

    Huang KP, Mullangi S, Guo Y, Qureshi AA.

    Abstract

    OBJECTIVE To evaluate the prevalence of comorbid conditions among patients with alopecia areata (AA) seen at tertiary care hospitals in Boston, Massachusetts, during an 11-year period. DESIGN Retrospective cross-sectional study. SETTING Tertiary care hospitals in Boston, including Brigham and Women's Hospital and Massachusetts General Hospital. PARTICIPANTS We identified 3568 individuals with AA seen in the Partners health care system in Boston between January 1, 2000, and January 1, 2011. We performed comprehensive searches of the Research Patient Data Repository using International Classification of Diseases, Ninth Revision code 704.01. We randomly selected 350 patients and manually reviewed their medical records to train and validate a novel artificial intelligence program. This program then used natural language processing to review free-text medical records and confirm a diagnosis of AA. To confirm the algorithm, we manually reviewed a subset of records and found 93.9% validity. MAIN OUTCOMES AND MEASURES The prevalence of comorbid conditions was assessed. RESULTS Common comorbid conditions included autoimmune diagnoses (thyroid disease in 14.6%, diabetes mellitus in 11.1%, inflammatory bowel disease in 6.3%, systemic lupus erythematosus in 4.3%, rheumatoid arthritis in 3.9%, and psoriasis and psoriatic arthritis in 2.0%), atopy (allergic rhinitis, asthma, and/or eczema in 38.2% and contact dermatitis and other eczema in 35.9%), and mental health problems (depression or anxiety in 25.5%). We also found high prevalences of hyperlipidemia (24.5%), hypertension (21.9%), and gastroesophageal reflux disease (17.3%). This profile was different from that seen in a comparison psoriasis and psoriatic arthritis group. CONCLUSIONS AND RELEVANCE We found a high prevalence of comorbid conditions among individuals with AA presenting to academic medical centers in Boston. Physicians caring for patients with AA should consider screening for comorbid conditions.

    Modiefied for hair loss treatment and hair regrowth blog use

    Permalink
  • doctorproctor.com

    Hair Loss and Hair Loss Treatment

    Permalink
  • Donnaproctor.com Permalink
  • drp hair loss site

    Hair Loss Treatment

    Permalink
  • drugscom.com Permalink
  • Gohair loss site Permalink
  • Gohair.com blog Permalink
  • Hair-Loss-Treatment.com

    Hair-Loss-Treatment.com enough said.

    Permalink
  • Hair-raising. The latest news on male-pattern baldness.

    Adv Nurse Pract. 1999 Apr;7(4):39-42, 83. Hair-raising. The latest news on male-pattern baldness.
    Proctor PH.

    The initiating event in balding seems to be an abnormal sensitivity to the male sex hormones. In addition, a multifactorial model is emerging in which hormones affect the hair follicle in a way that causes it to be perceived as a foreign body by the immune system, which then mounts an attack. Several new classes of agents have the potential to treat hair loss. More than 40 U.S. and several hundred foreign patents have been issued for hair-loss treatment agents. As is common in dermatology, no single agent works universally against hair loss, so the treatment process is often one of trial and error.

    This is a paper by Dr. Proctor

    Permalink
  • nitrone blog Permalink

Misc

XML Feeds

What is RSS?

Who's Online?

  • Guest Users: 4

powered by b2evolution free blog software